Roche Holding AG is required to pay eighteen million dollars to two formers users of the acne medication Accutane after a jury found the drug responsible for the bowel disease the two women suffered. The Atlantic City, New Jersey jury awarded $9 million to each of the women, but failed to find Roche at fault in the cases of two other Accutane users. The panel concluded Roche did not properly warn Riley Wilkinson and Kathleen Rossitto taking Accutane could lead to inflammatory bowel disease.
Released in 1982, Accutane was formerly the second-biggest selling medication from Roche with approximately sixteen million people taking the drug. The company removed the drug from the market after many juries awarded plaintiffs large damage awards that suffered from bowel issues related to Accutane.
If you or a family member suffered severe side effects from Accutane or a prescription medication, a defective drugs lawyer may be able to help you pursue compensation. Call 1-888-BURNETTI for more information.